Anhui Huaheng Biotechnology Co., Ltd. (SHA:688639)

Market Cap	5.61B -22.6%
Revenue (ttm)	2.95B +24.6%
Net Income	123.41M -19.9%
EPS	0.50 -24.6%
Shares Out	249.40M
PE Ratio	45.21
Forward PE	17.59
Dividend	0.16 (0.68%)
Ex-Dividend Date	May 12, 2026

Volume	6,143,729
Open	23.71
Previous Close	23.57
Day's Range	22.40 - 23.71
52-Week Range	22.42 - 43.60
Beta	0.18
Analysts	Strong Buy
Price Target	45.25 (+101.02%)
Earnings Date	Aug 28, 2026

About SHA:688639

Anhui Huaheng Biotechnology Co., Ltd. engages in the research and development, production, and sale of bio-based products through bio-manufacturing in China and internationally. The company offers amino acid products, including the alanine series, L-valine, isoleucine, tryptophan, and arginine; vitamin products, such as D-calcium pantothenate, D-panthenol, and inositol; bio-based new material monomers, including 1,3-propanediol and succinic acid; and other products, including malic acid and arbutin. Its products are used in daily chemical produ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2005
• Employees: 2,252
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688639

Financial Performance

In 2025, SHA:688639's revenue was 2.86 billion, an increase of 31.40% compared to the previous year's 2.18 billion. Earnings were 132.41 million, a decrease of -30.13%.

Analyst Summary

According to 2 analysts, the average rating for 688639 stock is "Strong Buy." The 12-month stock price target is ¥45.25, which is an increase of 101.02% from the latest price.

Price Target

¥45.25

(101.02% upside)

Analyst Consensus: Strong Buy